IMMUNIC, INC. Files 8-K Report
Ticker: IMUX · Form: 8-K · Filed: May 28, 2025 · CIK: 1280776
| Field | Detail |
|---|---|
| Company | Immunic, INC. (IMUX) |
| Form Type | 8-K |
| Filed Date | May 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, reporting
TL;DR
IMMUNIC, INC. filed a routine 8-K, nothing major to see here.
AI Summary
On May 28, 2025, IMMUNIC, INC. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific financial figures or new material events were detailed in the provided excerpt, but the filing indicates ongoing corporate reporting activities.
Why It Matters
This filing indicates IMMUNIC, INC. is fulfilling its regular reporting obligations with the SEC, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting other events and financial statements, not indicating any immediate material changes or risks.
Key Players & Entities
- IMMUNIC, INC. (company) — Registrant
- May 28, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 1200 Avenue of the Americas, Suite 200 New York, NY 10036 (address) — Principal Executive Offices
- (332) 255-9818 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for IMMUNIC, INC.?
The filing is a Current Report on Form 8-K, reporting "Other Events" and "Financial Statements and Exhibits" as of May 28, 2025.
What is IMMUNIC, INC.'s state of incorporation?
IMMUNIC, INC. is incorporated in Delaware.
What is the principal executive office address for IMMUNIC, INC.?
The principal executive offices are located at 1200 Avenue of the Americas, Suite 200, New York, NY 10036.
What is the IRS Employer Identification Number for IMMUNIC, INC.?
The IRS Employer Identification Number for IMMUNIC, INC. is 56-2358443.
When was the earliest event reported in this filing?
The earliest event reported is dated May 28, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 28, 2025 regarding IMMUNIC, INC. (IMUX).